substance p has been researched along with Adenoma, Prostatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burnstock, G; Crowe, R; Milroy, EJ; Noble, J; Robson, T; Soediono, P | 1 |
| Cariou, G; Cortesse, A; Cussenot, O; Desgrandchamps, F; Fiet, J; Le Duc, A; Meria, P; Teillac, P; Valeri, A; Villette, JM | 1 |
2 other study(ies) available for substance p and Adenoma, Prostatic
| Article | Year |
|---|---|
An increase of neuropeptide Y but not nitric oxide synthase-immunoreactive nerves in the bladder neck from male patients with bladder neck dyssynergia.
Topics: Adult; Amino Acid Oxidoreductases; Calcitonin Gene-Related Peptide; Humans; Immunohistochemistry; Male; Nerve Tissue Proteins; Neurons; Neuropeptide Y; Nitric Oxide Synthase; Prostatic Hyperplasia; Substance P; Thiolester Hydrolases; Ubiquitin Thiolesterase; Urinary Bladder; Urinary Bladder Neck Obstruction; Vasoactive Intestinal Peptide | 1995 |
Plasma neuroendocrine markers in patients with benign prostatic hyperplasia and prostatic carcinoma.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Biomarkers, Tumor; Bombesin; Calcitonin; Chromogranin A; Chromogranins; Humans; Immunoassay; Male; Middle Aged; Neuropeptides; Neurotensin; Phosphopyruvate Hydratase; Prognosis; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Somatostatin; Substance P; Survival Rate | 1996 |